Characterization of the prediabetic state

American Journal of Hypertension

Volumn 10, Issue 9 SUPPL. 1, 1997, Pages 172S-180S

  Groop, Leif ^a   Forsblom, Carol ^b   Lehtovirta, Mikko ^b  

^a LUND UNIVERSITY   (Sweden)

^b UNIVERSITY OF HELSINKI   (Finland)

Author keywords

Hypertension; Insulin resistance; Microalbuminuria; Non insulin dependent diabetes mellitus; Prediabetes

Indexed keywords

GLUCOSE; INSULIN;

ADULT; ARTICLE; CONTROLLED STUDY; DISEASE PREDISPOSITION; EXTRACHROMOSOMAL INHERITANCE; FATTY ACID METABOLISM; FEMALE; GENOTYPE; GLUCOSE CLAMP TECHNIQUE; HUMAN; HYPERGLYCEMIA; HYPERTENSION; IMPAIRED GLUCOSE TOLERANCE; INSULIN RELEASE; INSULIN RESISTANCE; MAJOR CLINICAL STUDY; MALE; MATURITY ONSET DIABETES MELLITUS; METABOLIC DISORDER; MICROALBUMINURIA; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; ORAL GLUCOSE TOLERANCE TEST; PRIORITY JOURNAL; SYNDROME X;

DIABETES MELLITUS, TYPE 2; DISEASE PROGRESSION; FORECASTING; HUMANS; INSULIN; INSULIN RESISTANCE; OBESITY; PREDIABETIC STATE;

EID: 0030860563     PISSN: 08957061     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (67)

1. Zimmet P: Diabetes care and prevention - around the world in 80 days, in Rifkin HCJ, Taylor SI (eds): Diabetes. Elsevier, Amsterdam, 1991, pp 721-729.
2. Bogardus C, Lillioja S, Nyomba B, et al: Distribution of in vivo insulin action in Pima Indians as mixture of three normal distributions. Diabetes 1989;38:1423-1432.
3. Serjeantson S, Owerbach D, Zimmet P, et al: Genetics of diabetes in Nauru: Effects of foreign admixture, HLA antigens, and the insulin-gene linked polymorphism. Diabetologia 1983;25:13-17.
4. Newman B, Selby J, King M, et al: Concordance for type 2 diabetes in male twins. Diabetologia 1987;30:763-768.
5. Köbberling J, Tillil H (eds): Empiricial Risk Figures for First-Degree Relatives of Non-Insulin-Dependent Diabetics. Academic Press, London, 1982.
6. Alcolado J, Alcolado R: Importance of maternal history of non-insulin-dependent diabetic patients. Br Med J 1991;302:1178-1180.
7. Thomas F, Balkau B, Vauzelle-Kevroedan F, et al: Maternal effect and familial aggregation of NIDDM. The CODIAB study. Diabetes 1994;43:63-67.
8. Groop L, Forsblom C, Lehtovirta M, et al: Metabolic consequences of a family history of NIDDM (The Botnia Study): evidence for sex-specific parental effects. Diabetes 1996;45:1585-1593.
9. Mitchell B, Kammerer C, Reinhart L, et al: Is there an excess in maternal transmission of NIDDM? Diabetologia 1995;38:314-317.
10. Groop L, Bonadonna R, DelPrato S, et al: Glucose and free fatty acid metabolism in non-insulin-dependent diabetes mellitus: evidence for multiple sites of insulin resistance. J Clin Invest 1989;84:205-213.
11. Groop L, Widén E, Ferrannini E: Insulin resistance and insulin deficiency in the pathogenesis of type 2 diabetes mellitus: inborn errors of metabolism or of methods? Diabetologia 1993;36:1326-1331.
12. Taylor S, Kadowaki T, Kadowaki H, et al: Mutations in the insulin receptor gene in insulin-resistant patients. Diabetes Care 1991;13:257-259.
13. Yki-Järvinen H. Acute and chronic effects of hyperglycemia on glucose metabolism. Diabetologia 1990;33: 579-585.
14. Eriksson J, Franssila-Kallunki A, Ekstrand A, et al: Early metabolic defects in persons at increased risk for non-insulin-dependent diabetes mellitus. New Engl J Med 1989;321:337-343.
15. Gulli G, Ferrannini E, Stern M, et al: The metabolic profile of NIDDM is fully established in glucose-tolerant offspring of two Mexican-American parents. Diabetes 1992;41:1575-1586.
16. Vaag A, Henriksen J, Beck-Nielsen H: Decreased activation of glycogen synthase in skeletal muscle of young nonobese Caucasian first-degree relatives of patients with non-insulin-dependent diabetes mellitus. J Clin Invest 1992;89:782-788.
17. Beck-Nielsen H, Groop L: Metabolic and genetic characterization of prediabetic states. Sequence of events leading to non-insulin-dependent diabetes mellitus. J Clin Invest 1994;94:1714-1721.
18. Rothman D, Magnusson I, Cline G, et al: Decreased muscle glucose transport/phosphorylation is an early defect in the pathogenesis of non-insulin-dependent diabetes mellitus. Proc Natl Acad Sci USA 1995;92:983-987.
19. Price T, Perseghin G, Duleba A, et al: NMR studies of muscle glycogen synthesis in insulin-resistant offspring of parents with non-insulin-dependent diabetes mellitus immediately after glycogen depleting exercise. Proc Natl Acad Sci 1996;93:5329-5334.
20. Ravussin E, Lillioja S, Knowler W, et al: Reduced rate of energy expenditure as a risk factor for body-weight gain. N Engl J Med 1988;318:467-472.
21. Groop L, Ekstrand A, Forsblom C, et al: Insulin resistance, hypertension and microalbuminuria in patients with type 2 diabetes mellitus. Diabetologia 1993;36: 642-647.
22. Nosadini R, Solini A, Velussi M, et al: Impaired insulin-induced glucose uptake by extrahepatic tissue is a hallmark of NIDDM patients who have or will develop hypertension or microalbuminuria. Diabetes 1994;43: 493-499.
23. Ferrannini E, Buzzigoli G, Bonadonna R, et al: Insulin resistance in essential hypertension. N Engl J Med 1987; 317:350-357.
24. Forsblom C, Eriksson J, Ekstrand A, et al: Insulin resistance and abnormal albumin excretion in non-diabetic first-degree relatives of patients with NIDDM. Diabetologia 1995;38:363-369.
25. Lehto M, Tuomi T, Mahtani M, et al: Characterization of the MODY3 phenotype: early-onset diabetes caused by an insulin secretion defect. J Clin Invest 1996;99:582-591.
26. Mahtani M, Widen E, Lehto M, et al: Mapping of a gene for type 2 diabetes associated with an insulin secretion defect by a genome scan in Finnish families. Nature Genetics 1996;14:90-94.
27. Widén E, Ekstrand A, Saloranta C, et al: Insulin resistance in type 2 diabetic patients with hypertriglyceridemia. Diabetologia 1992;35:1140-1145.
28. Vuorinen-Markkola H, Yki-Järvinen H: Hyperuricemia and insulin resistance. J Clin Endocrinol Metab 1994; 78:25-28.
29. Reaven G: Role of insulin resistance in human disease. Diabetes 1988;37:1595-1607.
30. Lillioja S, Young A, Cutler C, et al: Skeletal muscle capillary density and fiber type are possible determinants of in vivo insulin resistance in man. J Clin Invest 1987;80:415-424.
31. Laakso M, Edelman S, Brechtel G, Baron A: Impaired insulin-mediated skeletal muscle blood flow in patients with NIDDM. Diabetes 1992;41:1076-1083.
32. Wells A, Sutcliffe I, Johnson A, Taylor R: Abnormal activation of glycogen synthase in fibroblasts from NIDDM patients. Evidence for an abnormality specific to glucose metabolism. Diabetes 1993;42:583-589.
33. Henry R, Ciaraldi T, Abrams-Carter L, et al: Glycogen synthase activity is reduced in cultured skeletal muscle cells of non-insulin-dependent diabetes mellitus subjects: biochemical and molecular mechanisms. J Clin Invest 1996;98:1231-1236.
34. Eriksson K-F, Saltin B, Lindgärde F: Increased skeletal muscle capillary density precedes diabetes development in men with impaired glucose tolerance. A 15-year follow-up study. Diabetes 1994;43:805-808.
35. Neel V: Diabetes mellitus: a "thrifty" genotype rendered detrimental by progress? Am J Hum Genet 1962; 14:352-362.
36. Coleman D: Obesity genes: beneficial effects in heterozygous mice. Science 1979;203:663-665.
37. Banerji M, Chaiken R, Gordon D, et al: Does intraabdominal adipose tissue in black men determine whether NIDDM is insulin-resistant or insulin-sensitive? Diabetes 1995;44:141-146.
38. Zhang Y, Proenca R, Maffei M, et al: Positional cloning of the mouse obese gene and its human homologue. Nature 1994;372:425-432.
39. Lönnqvist F, Thörne A, Nilsell K, et al: A pathogenetic role of visceral fat beta-3-adrenoreceptors in obesity. J Clin Invest 1995;95:1109-1116.
40. Hoffstedt J, Wahrenberg H, Thörne A, Lönnqvist F: The metabolic syndrome is related to beta-3-adrenoceptor sensitivity in visceral adipose tissue. Diabetologia 1996; 39:838-844.
41. Clément K, Vaisse C, Manning B, et al: Genetic variation in the beta3-adrenergic receptor and an increased capacity to gain weight in patients with morbid obesity. N Engl J Med 1995;333:352-354.
42. Walston J, Silver K, Bogardus C, et al: Time of onset of non-insulin-dependent diabetes mellitus and genetic variation in the beta3-adrenergic-receptor gene. N Engl J Med 1995;333:343-347.
43. Widèn E, Lehto M, Kanninen T, et al: Association of a polymorphism in the beta-3-adrenergic-receptor gene with features of the insulin resistance syndrome in Finns. N Engl J Med 1995;333:348-351.
44. Yoshida T, Sakane N, Umekawa T, et al: Mutations in the beta-3-adrenergic-receptor gene and response to treatment of obesity. Lancet 1995;346:1433-1434.
45. Urhammar S, Clausen J, Hansen T, Pedersen O: Insulin sensitivity and body weight changes in young white carriers of the codon 64 amino acid polymorphism of the beta-3-adrenergic receptor gene. Diabetes 1996;45: 1115-1120.
46. Kurabayashi T, Carey D, Morrison N: The beta3-adrenergic receptor gene Trp64Arg mutation is overrepresented in obese women. Effects on weight, BMI, abdominal fat, blood pressure, and reproductive history in an elderly Australian population. Diabetes 1996;45: 1358-1363.
47. Li L, Lönnqvist F, Luthman H, Arner P: Phenotypic characterization of the Trp64Arg polymorphism in the beta-3-adrenergic receptor gene in normal weight and obese subjects. Diabetologia 1996;39:857-860.
48. Mauriége P, Bouschard C: Trp64Arg mutation in beta3-adrenoceptor gene of doubtful significance for obesity and insulin resistance. Lancet 1996;348:698-699.
49. Nagase I, Yoshida T, Kumamoto K, et al: Expression of uncoupling protein in skeletal muscle and white fat of obese mice treated with thermogenic beta3-adrenergic agonists. J Clin Invest 1996;97:2898-2903.
50. Falholt K, Jensen I, Lindkaer Jensen S, et al: Carbohydrate and lipid metabolism of skeletal muscle in type 2 diabetic patients. Diabet Med 1987;5:27-31.
51. Borkman M, Storlien L, Pan D, et al: The relation between insulin sensitivity and the fatty acid composition of skeletal muscle phospholipids. New Engl J Med 1993;328:238-244.
52. Storlien L, Jenkins A, Chisholm D, et al: Influence of dietary fat composition on development of insulin resistance in rats. Relationship to muscle triglyceride and omega-3 fatty acids in muscle phospholipid. Diabetes 1991;40:280-289.
53. Groop L, Ferrannini E: Insulin action and substrate competition, in Ferrannini E (ed): Baillière's Clinical Endocrinology and Metabolism 1993;7:1007-1032.
54. Cerasi E, Luft R: The plasma insulin response to glucose infusion in healthy subjects and in subjects with diabetes mellitus. Acta Endocrinol 1967;55:278-304.
55. Pimenta W, Korytkowski M, Mitrakou A, et al: Pancreatic beta-cell dysfunction as the primary genetic lesion in NIDDM. JAMA 1995;273:1855-1861.
56. Byrne M, Sturis J, Sobel R, Polonsky K: Elevated plasma glucose 2 h postchallenge predicts defects in beta-cell function. Am J Physiol 1996;E270:E572-E579.
57. Groop L, Bottazzo G, Doniach D: Islet cell antibodies identify latent type 1 diabetes in patients aged 35-75 years at diagnosis. Diabetes 1986;35:237-241.
58. Tuomi T, Groop L, Zimmet P, et al: Antibodies to glutamic acid decarboxylase (GAD) identify latent IDDM in patients with onset of diabetes after the age of 35 years. Diabetes 1993;42:359-362.
59. Carlsson Å-L, Tuomi T, Li H, Forsblom C, Groop L. LADA is genetically different from IDDM (abst). Diabetologia 1996;39(suppl 1):A47.
60. Martin B, Warram J, Krolewski A, et al: Role of glucose and insulin resistance in development of type 2 diabetes mellitus: results of a 25-year follow-up study. Lancet 1992;340:925-929.
61. Skarfors E, Selenus K, Lithell H: Risk factors for developing non-insulin-dependent diabetes mellitus: a 10-year follow-up of men in Uppsala. Br Med J 1991;303:755-760.
62. Ohlson L, Larsson B, Svärdsudd K, et al: The influence of body fat distribution on the incidence of diabetes mellitus: 13.5 years of follow-up of the participants in the study of men born in 1913. Diabetes 1985;34:1055-1058.
63. Lillioja S, Mott D, Spraul M, et al: Insulin resistance and insulin secretory dysfunction as precursors of non-insulin-dependent diabetes mellitus. N Engl J Med 1993;329:1988-1992.
64. Eriksson K-F, Lindgärde F: Poor physical fitness, and impaired early insulin response but late hyperinsulinemia, as predictors of NIDDM in middle-aged Swedish men. Diabetologia 1996;39:573-579.
65. Warram J, Martin B, Krolewski A, et al: Slow glucose removal rate and hyperinsulinemia precede the development of type II diabetes in offspring of diabetic parents. Ann Intern Med 1990;113:909-915.
66. Lillioja S, Mott D, Howard B, et al: Impaired glucose tolerance as disorder of insulin action. Longitudinal and cross-sectional studies in Pima Indians. N Engl J Med 1987;20:87-93.
67. Laakso M, Barrett-Connor E: Asymtomatic hyperglycemia is associated with lipid and lipoprotein changes favouring atherosclerosis. Arteriosclerosis 1989;9:665-672.